GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia - PubMed (original) (raw)
Comparative Study
. 2004 May 15;76(4):581-92.
doi: 10.1002/jnr.20122.
Affiliations
- PMID: 15114630
- DOI: 10.1002/jnr.20122
Comparative Study
GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia
Stella Dracheva et al. J Neurosci Res. 2004.
Abstract
Gamma-Aminobutyric acid (GABA), the principal inhibitory neurotransmitter of CNS, has been consistently implicated in the pathophysiology of schizophrenia. GABA is synthesized from glutamate by the enzyme glutamic acid decarboxylase (GAD). Two isoforms of GAD have been identified and have been named GAD65 and GAD67 based on their apparent molecular weights. In this study, GAD65 and GAD67 mRNA and protein levels were measured by using real-time RT-PCR and immunoblotting, respectively, in post-mortem brain tissue from the dorsolateral prefrontal cortex (DLPFC) and the occipital cortex of the elderly persons with schizophrenia and matched normal controls. In addition, the mRNA expression of GAT-1, one of the principal transporters of GABA, was also studied in the same subjects. Expression of GAD65 and GAD67 mRNA in the DLPFC and in the occipital cortex was significantly elevated in patients with schizophrenia, whereas the expression of the corresponding proteins and GAT-1 mRNA was unchanged. Although the levels of GAD65 and GAD67 messages were increased in schizophrenia subjects, the proportion of the two GAD isoforms remained constant in controls and schizophrenics. In the human DLPFC, GAD65 mRNA was found to be expressed significantly less than the message for GAD67, approximately 16% of that observed for GAD67. On the contrary, the abundance of GAD65 protein in the DLPFC was about 350% of that observed for GAD67. The results suggest a substantial dysregulation of GAD mRNA expression in schizophrenia and, taken together with the results of protein expression studies, raise the possibility that both cortical and subcortical GABA function may be compromised in the disease.
Copyright 2004 Wiley-Liss, Inc.
Similar articles
- Expression of plasma membrane GABA transporters but not of the vesicular GABA transporter in dentate granule cells after kainic acid seizures.
Sperk G, Schwarzer C, Heilman J, Furtinger S, Reimer RJ, Edwards RH, Nelson N. Sperk G, et al. Hippocampus. 2003;13(7):806-15. doi: 10.1002/hipo.10133. Hippocampus. 2003. PMID: 14620876 - Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus.
Freichel C, Potschka H, Ebert U, Brandt C, Löscher W. Freichel C, et al. Neuroscience. 2006 Sep 15;141(4):2177-94. doi: 10.1016/j.neuroscience.2006.05.040. Epub 2006 Jun 23. Neuroscience. 2006. PMID: 16797850 - mRNA expression of AMPA receptors and AMPA receptor binding proteins in the cerebral cortex of elderly schizophrenics.
Dracheva S, McGurk SR, Haroutunian V. Dracheva S, et al. J Neurosci Res. 2005 Mar 15;79(6):868-78. doi: 10.1002/jnr.20423. J Neurosci Res. 2005. PMID: 15696539 - Molecular and cellular mechanisms of altered GAD1/GAD67 expression in schizophrenia and related disorders.
Akbarian S, Huang HS. Akbarian S, et al. Brain Res Rev. 2006 Sep;52(2):293-304. doi: 10.1016/j.brainresrev.2006.04.001. Epub 2006 Jun 8. Brain Res Rev. 2006. PMID: 16759710 Review. - Are GAD65 and GAD67 associated with specific pools of GABA in brain?
Martin DL, Barke KE. Martin DL, et al. Perspect Dev Neurobiol. 1998;5(2-3):119-29. Perspect Dev Neurobiol. 1998. PMID: 9777630 Review.
Cited by
- Systemic neurochemical alterations in schizophrenic brain: glutamate metabolism in focus.
Burbaeva GSh, Boksha IS, Tereshkina EB, Savushkina OK, Starodubtseva LI, Turishcheva MS, Mukaetova-Ladinska E. Burbaeva GSh, et al. Neurochem Res. 2007 Sep;32(9):1434-44. doi: 10.1007/s11064-007-9328-7. Epub 2007 Apr 18. Neurochem Res. 2007. PMID: 17440811 - GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders.
Davis KN, Tao R, Li C, Gao Y, Gondré-Lewis MC, Lipska BK, Shin JH, Xie B, Ye T, Weinberger DR, Kleinman JE, Hyde TM. Davis KN, et al. PLoS One. 2016 Feb 5;11(2):e0148558. doi: 10.1371/journal.pone.0148558. eCollection 2016. PLoS One. 2016. PMID: 26848839 Free PMC article. - microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder.
Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jin J, Hammond SM. Perkins DO, et al. Genome Biol. 2007;8(2):R27. doi: 10.1186/gb-2007-8-2-r27. Genome Biol. 2007. PMID: 17326821 Free PMC article. - Schizophrenia and sex associated differences in the expression of neuronal and oligodendrocyte-specific genes in individual thalamic nuclei.
Byne W, Dracheva S, Chin B, Schmeidler JM, Davis KL, Haroutunian V. Byne W, et al. Schizophr Res. 2008 Jan;98(1-3):118-28. doi: 10.1016/j.schres.2007.09.034. Epub 2007 Oct 29. Schizophr Res. 2008. PMID: 18029146 Free PMC article. - Cholinergic connectivity: it's implications for psychiatric disorders.
Scarr E, Gibbons AS, Neo J, Udawela M, Dean B. Scarr E, et al. Front Cell Neurosci. 2013 May 3;7:55. doi: 10.3389/fncel.2013.00055. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23653591 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical